Tower Research Capital LLC (Trc) Precipio, Inc. Transaction History

Tower Research Capital LLC (Trc)

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$0.33 - $0.7 $54 - $116	-166 Reduced 1.81%	9,004 $3,000
Q1 2023 May 09, 2023	SELL	$0.6 - $1.0 $3,036 - $5,060	-5,060 Reduced 35.56%	9,170 $6,000
Q4 2022 Feb 10, 2023	BUY	$0.5 - $17.4 $1,240 - $43,169	2,481 Added 21.12%	14,230 $8,000
Q3 2022 Nov 10, 2022	BUY	$0.78 - $17.8 $5,153 - $117,604	6,607 Added 128.49%	11,749 $9,000
Q2 2022 Aug 15, 2022	BUY	$0.98 - $1.68 $90 - $154	92 Added 1.82%	5,142 $5,000
Q1 2022 May 12, 2022	SELL	$1.19 - $1.71 $2,159 - $3,103	-1,815 Reduced 26.44%	5,050 $7,000
Q4 2021 Feb 14, 2022	BUY	$1.58 - $2.77 $9,503 - $16,661	6,015 Added 707.65%	6,865 $11,000
Q3 2021 Nov 15, 2021	BUY	$2.78 - $3.63 $2,363 - $3,085	850 New	850 $2,000
Q2 2021 Aug 16, 2021	SELL	$1.8 - $5.25 $1,742 - $5,082	-968 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$2.1 - $3.89 $1,415 - $2,621	-674 Reduced 41.05%	968 $2,000
Q4 2020 Feb 16, 2021	BUY	$1.94 - $2.64 $3,185 - $4,334	1,642 New	1,642 $3,000

340

Ticker PRPO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 22,736,500
Market Cap $150M
Description
Precipio, Inc., a healthcare solutions company, provides diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; HemeScreen, a suite of robust geneti...

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.